Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Follicular × Mesna × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 3 Vomiting 2 Neoplasms 2 Nausea 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia 2 Hodgkin Disease 2 Thalassemia 1 Teratoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lymphoma, Follicular 1 Hepatoblastoma 1 Hematologic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 14 fludarabine phosphate 12 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 Filgrastim 9 Whole-Body Irradiation 8 Mycophenolic Acid 8 Radiotherapy 5 Busulfan 5 Antilymphocyte Serum 5 Therapeutics 4 Psychiatric Rehabilitation 4 Methylprednisolone 4 Melphalan 4 Exercise 4 Cord Blood Stem Cell Transplantation 4 Blood Specimen Collection 4 fludarabine 3 Rituximab 3 Prednisone 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Dexamethasone 3 plerixafor 2 Standard of Care 2 Methotrexate 2 Methods 2 Magnetic Resonance Spectroscopy 2 Flow Cytometry 2 Educational Status 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡